US 11230591
CMV neutralizing antigen binding proteins
granted A61PA61P31/22
Quick answer
US patent 11230591 (CMV neutralizing antigen binding proteins) held by The Board of Regents of the University of Texas System expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P31/22